New research reveals that people who discontinue popular weight-loss injections like Mounjaro or Wegovy may regain reduced body mass at a significantly accelerated pace than those who halt traditional lifestyle regimens.
Published data in a prominent medical journal demonstrates that while overweight people can lose substantial amounts of their total mass while using the jabs, the mass returns at an average rate of 0.8 kg per month after stopping.
"People buying these medications must be informed of the potential of rapid rebound weight gain when the medication ends," warns researcher Dr. Susan Jebb.
That rate of recovery means a reversion to pre-treatment weight in about a year and a half.
Analyzing Therapies
The study, which examined 37 of trials involving over 9,000 of participants, compared the outcomes of GLP-1 agonists with conventional dieting.
The team emphasize that individuals who shed pounds through lifestyle changes alone typically have a more gradual weight regain—perhaps 0.1 kg a month—once they finish.
Explaining the Fast Regain
Nutrition scientists propose the mechanism of the drugs explains the accelerated weight return.
The injections copy a body's own chemical called glucagon-like peptide-1, which helps regulate appetite.
"Long-term administration of GLP-1 concentrations several times higher than the body's typical production might result in the system to generate a reduced amount of its own natural GLP-1, and could reduce responsiveness to its actions," said Dr. Adam Collins, a nutrition specialist.
"Discontinuation of this hormone supplement leads to appetite is no longer kept in check, making excessive eating far more likely."
A Chronic Disease?
The NHS advise the jabs for individuals with weight-linked medical conditions, alongside recommended lifestyle changes.
Many experts argue that, considering the high risk of relapse, the therapy should be considered life-long.
This view is echoed by pharmaceutical companies, who state that the findings "highlight the chronic nature of excess weight," akin to managing conditions like hypertension.
User Testimonies
Individuals who have come off the medication explain a powerful return of cravings.
"It was like something flipping and I was suddenly extremely hungry," recalled an individual.
The struggle is worsened if users have not developed permanent dietary or behavioural changes during therapy.
Widespread Use
Figures indicate that millions of adults in the UK have used weight-loss jabs in the last 12 months, with demand being substantial.
- Adoption is higher among females compared to men.
- The middle-aged age group shows the highest usage rates.
- Many obtain the medications through private prescriptions rather than the NHS.
In conclusion, clinicians emphasize that while GLP-1 drugs are powerful tools for shedding pounds, they are not a magic fix and maintained weight loss hinges on ongoing lifestyle management.
